Protocol H8A-US-B004 Longitudinal Cohort Study of Resource use and Cost of Mild Cognitive Impairment and Mild Dementia due to Alzheimer’s Disease in the United States (GERAS-US)
To assess total costs associated with AD (amyloid positive) over 36 months stratified by the patients’ baseline AD stage of MCI due to AD or mild dementia due to AD.
Primary Investigator: Robert Keyes